LivePerson (LPSN) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +45.00%. A quarter ago, it was expected that this customer-service technology company would post a loss of $0.2 per share when it actually produced a loss of $0.19, delivering a surprise of +5%.Over the last four quarters, the ...

Macerich (MAC) came out with quarterly funds from operations (FFO) of $0.32 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to FFO of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of -5.88%. A quarter ago, it was expected that this shopping center real estate investment trust would post FFO of $0.31 per share when it actually produced FFO of $0.33, delivering a surprise of +6.45%.Over the last ...

Agenus (AGEN) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to a loss of $2.52 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -28.21%. A quarter ago, it was expected that this biotechnology company would post a loss of $1.61 per share when it actually produced a loss of $1.03, delivering a surprise of +36.02%.Over the last four quarters, the company has su ...

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +22.22%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.17 per share when it actually produced a loss of $0.24, delivering a surprise of -41.18%.Over the last fou ...

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to a loss of $0.64 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +69.37%. A quarter ago, it was expected that this pharmaceutical company would post a loss of $1.58 per share when it actually produced a loss of $0.52, delivering a surprise of +67.09%.Over the last four quarters, ...

Core Insights - ACV Auctions Inc. reported quarterly earnings of $0.07 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.02 per share a year ago [1] - The company posted revenues of $193.7 million for the quarter ended June 2025, which was 1.22% below the Zacks Consensus Estimate, but up from $160.62 million year-over-year [2] - The stock has underperformed, losing approximately 36.9% since the beginning of the year, while the S&P 500 has gained 8.6% [3] Earnings Performance - The company has surpassed consensus EPS estimates two times over the last four quarters [1] - ACV Auctions has topped consensus revenue estimates three times in the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $0.08, with expected revenues of $204.91 million, and for the current fiscal year, the estimate is $0.24 on revenues of $775.69 million [7] Market Outlook - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] - The industry, Auction and Valuation Services, is ranked in the bottom 16% of over 250 Zacks industries, suggesting a challenging environment for the stock [8] - The correlation between near-term stock movements and earnings estimate revisions is emphasized, indicating that investors should monitor these revisions closely [5]

Assertio (ASRT) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -70.00%. A quarter ago, it was expected that this drugmaker would post a loss of $0.06 per share when it actually produced a loss of $0.14, delivering a surprise of -133.33%.Over the last four quarters, the company has surpassed ...

BigBear.ai Holdings, Inc. (BBAI) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post a loss of $0.06 per share when it actually produced a loss of $0.1, delivering a surprise of -66.67%.Over the last four quarters, the company ...

BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -36.36%. A quarter ago, it was expected that this company would post a loss of $0.15 per share when it actually produced a loss of $0.13, delivering a surprise of +13.33%.Over the last four quarters, the company ...

Aris Water Solutions, Inc. (ARIS) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.83%. A quarter ago, it was expected that this company would post earnings of $0.23 per share when it actually produced earnings of $0.25, delivering a surprise of +8.7%.Over the last four quarters, t ...